Author

Prangya Paramita Sahoo

Centre for Cellular and Molecular BiologyORCID 0009-0001-8466-6429Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Krishnan Harinivas HarshaniD· 2 shared Vishal SahiD· 2 shared Anant Bahadur PateliD· 1 shared Debasmita Basu· 1 shared Dixit TandeliD· 1 shared K.S. Varadarajan· 1 shared Karthika S Nair· 1 shared Poojitha Sai PotharajuiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Krishnan Harinivas HarshanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 21, 2026

Snail restricts SARS-CoV-2 entry by limiting ACE2 expression as part of broader remodelling of epithelial determinants of viral tropism

Prangya Paramita Sahoo, Vishal Sah, Krishnan Harinivas Harshan

This study identifies Snail as a host restriction factor that limits SARS-CoV-2 entry by reducing ACE2 expression through transcriptional regulation and translational suppression.

DOI 10.64898/2026.10.20.760609

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 28, 2025

MAVS Safeguards Mitochondrial Integrity to Drive a Potent Intrinsic Antiviral Program

Vishal Sah, Poojitha Sai Potharaju, Karthika S Nair…·Krishnan Harinivas Harshan

This study identifies MAVS as a mitochondrial guardian that maintains mitochondrial integrity to drive IFN-independent antiviral immunity against SARS-CoV-2 and JEV.

DOI 10.1101/2025.04.28.651145

experimental assayhost-pathogen & immune response

𝕏 PostBluesky